2017-2018 ISPOR Board of Directors

Vote for 2018-2019 Board of Directors »


Shelby Reed

President (2017-2018)
Shelby D. Reed, RPh, PhD
Professor, Duke University
Durham, NC, USA

Lou Garrison

Past President (2017-2018)
Lou Garrison, PhD
Professor, Pharmaceutical Outcomes Research & Policy Program
School of Pharmacy University of Washington
Seattle, WA, USA

Joanna Lis

Director (2016-2018)
Joanna Lis, MSc, MBA, PhD
Director of Market Access,
Sanofi-Aventis
Warsaw, Poland

Gordon Liu

Director (2016-2018)
Gordon G. Liu, PhD
PKU Yangtze River Scholar Professor of Economics, Peking University National School of Development and Director, PKU China Center for Health Economic Research
Beijing, China

Rosanna Tarricone

Director (2016-2018)
Rosanna Tarricone, MSc, PhD
Associate Professor,
Bocconi University
Milan, Italy

John Watkins

Director (2016-2018)
John Watkins, MPH, PharmD
Formulary Manager,
Premera Blue Cross
Mountlake Terrace, WA, USA

Federico Augustovski

President-Elect (2017-2018)
Federico Augustovski, MD, MSc, PhD
Director, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET)
Buenos Aires, Argentina

Meindert Boysen

Director (2017-2020)
Meindert Boysen, PharmD, MSc
Program Director Technology Appraisals
National Institute for Health and Care Excellence (NICE)
Manchester, UK

Stephanie Earnshaw

Director (2017-2020)
Stephanie Earnshaw, PhD
Senior Vice President, Health Economics
RTI
Raleigh, NC, USA

Jan Hansen

Director (2017-2020)
Jan Elias Hansen, PhD
Vice President of Real World Evidence
Genentech
South San Francisco, CA, USA

Zeba Khan

Treasurer (2013-2020)
Zeba M. Khan, RPh, PhD
Vice President
Celgene Corporation
Summit, NJ, USA

Nancy S. Berg

CEO & Executive Director
Nancy S. Berg
CEO & Executive Director
International Society for Pharmacoeconomics
and Outcomes Research (ISPOR)
Lawrenceville, NJ, USA

ISPOR Boards of Directors 1995-2017 »